News

AES Clean Technology, a leading provider of high-performance cleanroom facilities within the pharmaceutical and bio-pharmaceutical industry, announced a $14.2 million investment to open a new manufacturing facility located in Manheim Borough, Lancaster County, Pennsylvania. The new state-of-the-art facility will see...

Last year, GlaxoSmithKline’s ViiV Healthcare’s feat of getting a long-awaited approval of HIV treatment by the name of Cabenuva was regarded as a peerless achievement since it eradicated the burden of taking a pill everyday. Another nod a year later...

It doesn’t come as a shock when we hear that GlaxoSmithKline and Gilead Sciences are fighting out in  HIV domain for a long time, just hoping for an access to success over the other, be it new launches or...

Biogen Inc. announced that it exercised its option to participate in the development and commercialization of mosunetuzumab. Biogen will pay a $30 million one-time option fee to Genentech, a member of the Roche Group, as part of the companies’...

Antiverse, a biotechnology company developing a computational antibody drug discovery platform, announced a partnership with a top 20 pharma company with core competencies in the life science fields of health care and nutrition. The collaboration has been successful in...

Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development of biopharmaceuticals and vaccines, announced the opening of its new ATMP development facilities under biosafety level S2 (BSL2 / S2). After one...

Pfizer Inc. and BioNTech SE announced that following a request from the U.S. FDA the companies have initiated a rolling submission seeking to amend the Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 Vaccine to include children 6 months...